CUP vs JCR: Side-by-Side Comparison
Compare Chugai Pharmaceutical Co. Ltd (CUP) and JCR Pharmaceuticals Co., Ltd. (JCR) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | CUP | JCR |
|---|---|---|
| Company | Chugai Pharmaceutical Co. Ltd | JCR Pharmaceuticals Co., Ltd. |
| Country / Exchange | Japan · DU | Japan · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Market cap | — | EUR 300.16M |
| P/E ratio | — | 24.6 |
| Dividend yield | — | 4.43% |
| Valuation model | — | 17.6% overvalued |
| Revenue (FY2025) | EUR 1.26T | EUR 33.07B |
| Revenue growth YoY | +7.5% | -22.9% |
| Net income | — | EUR -4.76B |
| Gross margin | 71.1% | 65.7% |
| Diluted EPS | 263.72 | -38.43 |